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In 2007, the 5-year survival rate for children with acute leukemia in Baja California, Mexico
was estimated at 10% (vs. 88% in the United States). In response, stakeholders at
St. Jude Children’s Research Hospital, Rady Children’s Hospital San Diego, and the
Hospital General de Tijuana (HGT) implemented a transcultural partnership to establish a
pediatric oncology program. The aimwas to improve clinical outcomes and overall survival
for children in Baja California. An initial needs assessment evaluation was performed
and a culturally sensitive, comprehensive, 5-year plan was designed and implemented.
After six years, healthcare system accomplishments include the establishment of a fully
functional pediatric oncology unit with 60 new healthcare providers (vs. five in 2007).
Patient outcome improvements include a rise in 5-year survival for leukemia from 10 to
43%, a rise in new cases diagnosed per year from 21 to 70, a reduction in the treatment
abandonment rate from 10% to 2%, and a 45% decrease in the infection rate. More
than 600 patients have benefited from this program. Knowledge sharing has taken place
between teams at the HGT and Rady Children’s Hospital San Diego. Further, one of
the most significant outcomes is that the HGT has transitioned into a regional referral
center and now mentors other hospitals in Mexico. Our results show that collaborative
initiatives that implement long-term partnerships along the United States–Mexico border
can effectively build local capacity and reduce the survival gap between children with
cancer in the two nations. Long-term collaborative partnerships should be encouraged
across other disciplines in medicine to further reduce health disparities across the United
States–Mexico border.
Keywords: pediatric cancer, transcultural partnership, US–Mexico border, international oncology, health systems
strengthening, global health, border health
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Introduction
According to the World Bank, Mexico was the 11th most popu-
lated country in the world in 2011 with roughly 122,330,000 citi-
zens, and spent $620 US per capita on healthcare [6.2% of its gross
domestic product (GDP)], ranking 70th worldwide. Based on
published data, Mexico’s health outcomes seem to underperform
its healthcare expenditure rankings and GDP earnings, with some
healthcare outcomes ranking low, such as infant mortality rate
(97th), under-five mortality rate (87th), and access to improved
sanitation facilities (104th) (1).
In contrast to Mexico, the United States (US) is the third
highest healthcare spender at $8,895 US per capita (17.9% of its
GDP – the most of any country) (1). While increasing healthcare
expenditures does not necessarily correlate with better outcomes,
significant health disparities exist between the US and Mexico.
Nowhere are these disparities more obvious than in the 47 border-
straddling metropolises along the 1,989 mile-long US–Mexico
border.
Two of these border cities, San Diego, California, and Tijuana,
Baja California (a state also known as “Baja California Norte”),
share a 24 km-long border. Close to 60 million people cross
this border annually; therefore, it is the busiest land-border
crossing in the world. Two of the largest hospitals that provide
care to patients in these cities are Rady Children’s Hospital San
Diego (RCHSD), the largest children’s hospital in California and
the sixth largest children’s hospital in the US, and the Hos-
pital General de Tijuana (HGT), the largest public hospital in
northwestern Mexico. These two institutions are separated by
only 43 kilometers – a short 30-minute drive – and although
the international boundary is very distinct, this border region
is culturally, linguistically, demographically, and economically
blurred.
With more than 160,000 new cases of childhood cancer diag-
nosed annually worldwide, the survival gap for children with can-
cer in high-income countries (HIC) and low- or middle-income
countries (LMIC) is astounding (2, 3). Although we recognize
that grouping low- and middle-income countries together can
be problematic in making comparisons among diverse nations,
which include recently emerging economies such as Mexico, we
are grouping LMIC together in this report, as in published, related
literature elsewhere, due to the fact that these countries tend to
have similarly poor outcomes for children with cancer.
Five-year overall survival rates for children with cancer in HIC,
like the US, are often 80–90% as compared to anywhere between
5 and 60% for children in an LMIC like Mexico (2–7). This
survival gap reflects the great disparities that exist between the
healthcare infrastructures of these two categories of countries
regarding effective pediatric cancer care.
Mortality due to cancer constitutes an increasingly large pro-
portion of total childhood mortality in LMIC (8–10). Mexico is
no exception, and although the incidence of cancer has increased
from 150.3 per million children per year in 2010 to 156.9 in
2012, the mortality rate has been reported as 5.3 per 100,000
children and as high as 8.6 in adolescents (11, 12). Reasons for
increased morbidity and mortality related to childhood cancer
in Mexico and other LMIC are described in Table 1 (12, 13). In
these countries, pediatric cancer mortality represents a significant
TABLE 1 | Differences in pediatric cancer care between high-income
countries (HIC) and low- or middle-income countries (LMIC).
Feature HIC – 20% of population LMIC – 80%
of population
Access to Care Virtually 100% 10–70%
Causes of
treatment
failure
Relapse Late referrals
Toxicity
Cancer resistance
Advanced disease at
presentation
Abandonment of
treatment
Major current
focuses
Finding cures Increasing access to care
Improving quality of life
posttreatment
Improving survival
Reducing suffering
Activities Discovering disease mechanisms Preventing abandonment
Development of targeted therapies
Mitigating long-term complications
Educating the community
Adapting curative therapy
to local resources and
populations
source of largely preventable deaths. As the proportion of deaths
due to communicable diseases decreases, the proportion of deaths
due to cancer increases (2, 13).
Given the need for improved pediatric cancer care in the Mex-
ican border region and the proximity to San Diego, leaders at
RCHSD reached out to numerous hospitals in Tijuana to assess
interest in engaging in a binational, collaborative partnership to
establish a pediatric oncology unit in Tijuana and improve out-
comes for children with cancer. Among the institutions contacted,
theHGT responded and expressed its willingness. Subsequently in
2008, RCHSD, the St. Jude Children’s Research Hospital Interna-
tional Outreach Program (St. Jude IOP), and the HGT engaged
in this long-term partnership to find a sustainable, local solution
for the children with cancer of Baja California in need of life-
saving oncology care. To the best of our knowledge, as of 2008,
a transcultural partnership in pediatric oncology had not yet been
established between institutions located in such close proximity of
the same border.
Materials and Methods
Implementation: Initial Setting and Action Plan
Physicians from RCHSD performed an initial site visit assess-
ment at the HGT in May 2008. The St. Jude IOP had previously
developed tools to aid in performing needs assessments (14).
One of these tools was adapted to the local setting in Tijuana to
include elements needed to obtain national accreditation from the
Mexican Ministry of Health. (This tool and budgetary guidelines
can be requested from the corresponding author.) The assess-
ment analysis showed that, even though the hospital had a basic
infrastructure, the essential elements of a pediatric cancer unit,
including dedicated hospital space, uniform treatment protocols,
supportive care, trained physicians, nurses, and allied staff, were
lacking.
A bilingual and bicultural pediatric hematologist/oncologist
from RCHSD (PA) was designated to work with the leadership at
the HGT and designed a 5-year action plan to facilitate the imple-
mentation of the new pediatric oncology program. PA worked in
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close collaboration with RCHSD and St Jude IOP leadership. In
addition, she directly interacted with hospital leadership and key
stakeholders at the HGT at all levels. PA monitored the progress
by close collaboration and follow-up with all key stakeholders.
Careful attention was made to the suggestions and guidelines
previously published in the literature in regards to transcultural
partnership implementation (3, 10, 15–17) and the Health Sys-
tems Strengthening principles were followed (18). The specific
objectives of the St. Jude IOP-RCHSD-HGT partnership became
the following:
1. Infrastructure and clinical outcomes improvement by estab-
lishing a fully functional pediatric oncology unit within the
HGT in a culturally sensitive manner and tailored to the
local needs and healthcare system and developing a quality
assurance plan.
2. Capacity building by appointing a local program coordinator
at the HGT, maintaining frequent communication between
RCHSD and the HGT, and establishing and training a local,
dedicated team of physicians, nurses, and ancillary staff to
provide high-quality, specialized care.
3. Ensuring the long-term financial sustainability and provision
of medications, supplies, and equipment by facilitating the
pediatric oncology unit’s national accreditation and identifying
and supporting a local grassroots foundation affiliated with the
HGT to build a fundraising program aimed at subsidizing the
cost of expenses not covered by the public health system.
Results
Infrastructure and Clinical Outcomes
Improvements
Infrastructure Improvements
Before the partnership, it was not uncommon for the HGT to
assign 10–20 pediatric patients to a single room on the pediatric
ward. By August 2008, construction of a temporary pediatric
oncology unit with five rooms was completed. In this temporary
unit, cancer patients were able to receive care in an isolated envi-
ronment. The current oncology unit in use today was constructed
in 2011 and includes 10 isolated patient rooms, two intensive care
rooms, and adequate bathroom facilities; an outpatient clinic was
also completed with a procedure room, clinic rooms, an infusion
center, and a school for the children.
Table 2 shows some of the clinical workflow enhancements and
quality assurance components that were implemented in order to
improve the delivery of clinical care in these new facilities.
TABLE 2 | Clinical workflow improvements and quality assurance
components at the Hospital General de Tijuana pediatric oncology unit.
Adjustments to the process for lab draws
Provision of vital equipment and utilities: computers, internet, and phone service
Process optimization regarding medication administration
Reorganization of the space in the outpatient clinic and infusion center
Medical record documentation and establishment of a medical record archive
Development of local institutional guidelines and protocols, an institutional cancer
registry and a data management program
Four factors were essential to the infrastructure developments:
1. The creation of a start-up budget between St. Jude IOP, RCHSD
and the HGT to provide initial funding.
2. Assisting the HGT with its application for national accredita-
tion from the Mexican Ministry of Health. Such accreditation
ensured that the HGT would receive future funding from
Seguro Popular.
3. The close working relationship between key stakeholders at
RCHSD and at the HGT to create a large-scale, feasible plan.
4. The extra $1 million US provided by the Mexican federal
government to enhance the infrastructure at the HGT.
Patient Clinical Outcomes
The patient population tripled soon after the inception of the
program. Leukemia, lymphoma, and brain tumors have consti-
tuted the most common cancers diagnosed in this population,
and the disease breakdown seems to be a representative sample
of the tumor burden in Mexico (11, 12) as well as in HIC (19).
Significant improvements in patient outcomes are the direct result
of the establishment of a fully functional pediatric oncology unit, a
dedicated team that has worked to improve access to care for those
underserved patients who previously could not have afforded it,
the establishment of infection management, supportive care, and
transfusion protocols, and the implementation of a data manage-
ment program that has subsequently been used to guide clinical
decision making.
Figure 1 includes the Kaplan–Meier curves for overall survival
and event-free survival for patients treated at the HGT cancer
unit from 2008 to 2014. The 3-year overall survival rate for acute
lymphoblastic leukemia achieved at the HGT in less than 4 years
(from 2008 to 2011) was 70% and the event-free survival was 50%,
remarkable feats in such a short-time period.
Table 3 includes other patient outcome accomplishments at
the HGT. For example, deaths related to infections have dropped
FIGURE 1 | Kaplan–Meier overall survival (OS) and event-free survival
(EFS) curves for the patients with acute lymphoblastic leukemia at the
Hospital General de Tijuana pediatric cancer unit from 2008–2014.
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TABLE 3 | Selected clinical outcomes in pediatric oncology at the Hospital
General de Tijuana.
Category 2008 2014
New cases per year 21 70
3-year survival rate for acute lymphoblastic leukemia 10% 70%c
Relapse rate Unknown 22%
Abandonment rate 10% 2%
Mortality rate during induction therapy Unknown 5.3%a
Infection rate (# infections100/inpatient days–month) 3.3 1.8
Infection-related mortality rate 27% 0%b
aHigher rate when compared to institutions in high-income countries, but lower when
compared to other low- or middle income countries (20, 21).
bData from 2013.
cData from 2011.
TABLE 4 | Healthcare professional development progress at the pediatric
oncology unit, Hospital General de Tijuana, 2007–2015.
Position 2007
(N= 5)
2008
(N= 27)
2015
(N= 60)
Pediatric oncologists 0 1 3a
Pediatric hematologists 0 0 1a
Pediatric intensive care specialists 0 1 1
Anesthesiologists 0 0 1
Pediatric infectious disease specialists 1 1 1a
Trained pediatricians 0 6 8a
Nurses 1 10 31a
Psychologists 0 1 3a
Social workers 1 1 1a
Dieticians 0 1 1
Pharmacists 0 1 1a
Teachers 0 0 2a
Pathologists 1 1 1
Surgeons 1 1 1
Administrative assistants 0 1 2a
Ambulance drivers 0 1 1a
Data managers 0 0 1a
aExclusive to the Hospital General de Tijuana pediatric oncology unit.
dramatically from 25% in 2008 to 0% in 2013. Also, there has
been a 45% reduction in the infection rate over the same period.
In regard to the highly curable cancers like acute lymphoblastic
leukemia and lymphomas, the leaders of the program on both
sides of the border expect to achieve similar survival rates as those
for children in San Diego by 2020.
Capacity Building
Team Building Accomplishments
The establishment and training of a multidisciplinary healthcare
team is one of the most effective ways to achieve a high-quality
pediatric cancer program where resources are constrained (10,
16, 22), and the same has held true for the St. Jude IOP-RCHSD-
HGT partnership. A local pediatric oncologist was appointed as
the on-site coordinator to oversee the emerging projects. Table 4
reports the enhancements made to the teammakeup as viewed by
snapshots taken in 2007, 2008, and currently in 2015 that display
the type and number of healthcare professionals employed by the
HGT pediatric cancer unit in those years.
Training
Training for the physicians, nurses, and ancillary staff, including
social workers, psychologists, and data managers, has been one
of the pillars of this project. Training has taken place on-site and
in other partner sites affiliated with the St. Jude IOP, such as
Guatemala and Chile (3, 8). For the staff fluent in English and able
to cross the border, training has been conducted at RCHSD. More
than 6,000 hours of on-site and online training have been provided
to various staff members. Patients and families have also benefited
from education and counseling about nutrition, oral health, and
infection prevention.
One initial problem was the scarce number of pediatric oncol-
ogists trained to care for children with cancer. A “physician-
extender” model was used as a solution, where a physician with
training in one area pursues additional, specialized training to
expand the care he or she can provide (23).Within theHGT’s pedi-
atric cancer unit, there are currently eight general pediatricians
who obtained further pediatric oncology and infectious diseases
training to work as “physician-extenders” to provide specialized
care to critically ill patients.
Community outreach education and cancer workshops to edu-
cate local and regional healthcare providers and the general pub-
lic about pediatric cancer have been one of the principal goals
of the educational program. To date, nearly 2,500 community
health care providers in Baja California have been reached by this
initiative.
Each of these training efforts has notably changed the skill level,
dynamic, and culture of the multi-disciplinary team. Physicians
are now well-trained to care for patients with cancer; nurses now
feel respected as vital members of the team; and doctors and
nurses now work together with other professionals and provide
standard of care to their patients. A powerful change has taken
place within a relatively short period of time.
Financial Sustainability
National Accreditation
One of the priority action items since the planning stages of the
program has been the facilitation of the national accreditation to
ensure federal financing. None of the accomplishments related
to infrastructure and clinical outcomes would have been possible
without the constant funding provided by the Mexican national
government through Seguro Popular. Seguro Popular provides
a fixed amount of monies per patient per year based on the
diagnosis. For example, for a patient with acute lymphoblastic
leukemia, Seguro Popular disburses to accredited centers about
$10,000 US annually. This fund covers for the majority of med-
ications, including chemotherapy and antibiotics, supplies, and
direct hospital costs. The local state government through its Min-
istry of Health supports the salary for personnel, equipment, and
additional operational costs.
Thismodel has ensured a stable and predictable funding stream
to provide comprehensive care for pediatric cancer patients, an
essential element to the long-term success of any health system’s
strengthening effort (18).
Grassroots Foundation
Despite the immense financial contributions made by Seguro
Popular, the funds have not been sufficient to meet the HGT’s
needs. Therefore, local grassroots efforts have offered immense
support to the patients and their families. Patronato Pro-Hospital
de Tijuana – Patronato – is a local, apolitical organization founded
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in 2000 to support all patients at the HGT, which are often
vulnerable. Given that the HGT is the largest public, community
hospital in Northwestern Mexico, it serves as a safety net for the
poorest in Baja California; as a result, nearly all families that seek
care at theHGT live below the effective poverty line of $200US per
month. Among other services, Patronato provides food subsidies,
funding for some medications not covered under Seguro Popular
and lodging for families who reside outside Tijuana (about 35% of
families). This strategy facilitates access to care and helps prevent
abandonment of treatment. Thus, without Seguro Popular and the
philanthropic efforts of Patronato, patients at the HGT could not
have access to treatment and would more frequently be lost to
treatment abandonment, since the majority of patients receiving
care at the HGT cannot afford the high expenses associated to
oncology care, including the cost of travel to the HGT, food,
missing work for one or both parents to support their child,
and many other expenses. Since the inception of the partnership
program, cancer care has been provided free of all costs to all
patients younger than 18 years of age receiving care at the HGT
regardless of their income or socio-economic status. Moreover,
Patronato has been the vehicle for the disbursement of funds
provided by the St. Jude IOP-RCHSD partnership to sponsor all
training activities and salary supplementation for key personnel
at the HGT.
In addition, close relationships between leadership of the part-
nership program and Patronato have led to effective commu-
nity advocacy contributions to strengthen relationships with local
government leaders. This focus has been instrumental to the
successful launching and sustainability of the program.
Discussion
Collaborative partnerships in pediatric oncology between insti-
tutions in HIC and LMIC may overcome health disparities by
strengthening health systems and improving clinical outcomes for
children with cancer. Innovative and dynamic collaborative mod-
els, where an academic pediatric oncology center in a HIC estab-
lishes a long-term partnership with an emerging center in a LMIC
have been successful in improving survival rates for children
with cancer (13). One of such programs was established in 1986
between La Mascota Pediatric Hospital in Managua, Nicaragua,
and hospitals in Monza and Milan, Italy, and Bellinzona, Switzer-
land, with successful outcomes (10). Since then, the Monza Inter-
national School of Pediatric Hematology/Oncology and the St.
Jude IOP have become pioneers in facilitating new collaborative
programs throughout the world. To date, the St. Jude IOP has
established more than 20 programs in 15 countries. As a result,
5-year survival rates for children with cancer have significantly
increased in the regions where these partnerships have been
established (8, 15, 22), particularly for children who suffer from
acute lymphoblastic leukemia. In addition, these programs help
develop and strengthen local healthcare infrastructures in com-
prehensive, sustainable ways from the ground up (2, 8). These
partnerships are often based on proven Health Systems Strength-
ening principles, like holism, context and collaboration, social
mobility, capacity enhancement, equity, financial protection, and
evidence-informed action (18).
The Ethics of Transcultural Partnerships in
Healthcare
Numerous ethical principles have been at work throughout the
successful St. Jude IOP-RCHSD-HGT collaborative initiative. In
general, transcultural partnerships elicit several ethical issues
that should be addressed prior to engaging in the relationship.
They are not necessarily the classical principles of ethics such as
beneficence, maleficence, justice, or autonomy, but center around
an understanding of intercultural aspects and communications.
There should be an understanding of the dynamics between
each party with sensitivity to specific cultural norms and behav-
iors. There can be ethical conflicts that relate to relationships
and trust. Is the trust based on signed agreements or does it
depend on the relationship between the two parties? If the trust is
based on relationship, when and how does the relationship begin
and end?
One also needs to be aware of the differences between
autonomous decision making and paternalism. One partner
should not expect to come in and direct decisions. Rather, all
parties involved should guide each other and have a common
motivation, similar perspectives, and unifying goals. Specific eth-
ical issues will include potential sources of conflict such as emo-
tions, assumptions and perceptions, values, needs and goals, lack
of information or clarity, and individual styles of communication
and behavior. To achieve a successful working relationship, stake-
holders would benefit by separating any conflicts from concepts
of right and wrong, and considering looking at or doing things in
different ways that would be acceptable to all parties.
Overcoming Disparity in Mexico
Health disparities in pediatric oncology are well-documented,
as are the epidemiology and burden associated with childhood
cancer in developing countries (4, 13–15).
In 2012, the Mexican census reported 32,972,300 children aged
0–18 years, comprising 37% of the total population (11). Of those,
less than 8% are covered with commercial insurance and around
40% have access to healthcare through their employed parents
who are insured via social security programs (Instituto Mexicano
de Seguridad Social-IMSS). The overwhelming majority – over
50% – are uninsured children, whose parents are not salaried
workers, are rural residents, or unemployed. AllMexicans who are
uninsured are eligible for Seguro Popular coverage (11, 12).
InMexico, cancer is the sixth leading cause of death in children
1–4 years old and the second leading cause of death in children
5–14 years old (11, 12). Prior to 2008, outcomes were very poor
for children with cancer in Baja California (20, 21, 24), and
because a comprehensive pediatric cancer center did not exist in
Baja California at that time, newly diagnosed pediatric oncology
patients from the region traveled long distances to other hospitals
in Mexico to seek care, or sadly, died in their local communities
(20, 24). Some reasons why pediatric cancer care was still poor in
Baja California as compared to other regions of central Mexico
were because of the high poverty rate of the citizens of Tijuana
(25), the relative insufficient number of academic institutions in
Baja California, the scarcity of philanthropic initiatives support-
ing patients with chronic diseases, and the geographic isolation
that characterizes states not located on central Mexico (26–28).
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In addition, the Seguro Popular program created to cover for
oncology care only started in Mexico in 2007.
The economic differences between the US and Mexico have
contributed in part to some of the healthcare disparities that
extend into the discipline of pediatric oncology. Before 2008, there
was neither a pediatric oncology unit nor a pediatric oncologist
in all of Baja California. Lack of pediatric cancer care is a prob-
lem that has extended beyond the San Diego–Tijuana border. In
2012, Mexico had 3.6 pediatric oncologists per million children
under the age of 18 (2), while the US had 29.2 total pediatric
cancer specialists per million children (3). Large regional staffing
inequalities exist in Mexico (4), as 44% of oncologists are concen-
trated in Mexico City, and 18% are in Guadalajara andMonterrey,
the second and third largest cities (11, 12). On average, a pediatric
oncologist inMexico provides care to 65 new cancer cases per year
(11, 12), whereas in the US, an oncologist provides care to 10 new
cases annually (29).
The Mexican government acknowledged improvements
needed to be made to its healthcare system, including
improvements in pediatric cancer care; thus in 2006, the
highly-acclaimed Seguro Popular legislation was passed. Seguro
Popular is more properly known as the System of Social
Protection for Health, and within it exists the Fund for Protection
against Catastrophic Expenditures that specifically covers
pediatric oncology medical care. The Fund for Protection against
Catastrophic Expenditures was expanded in 2008 to include full
payment for all types of childhood cancers (9, 12, 24).
These initiatives targeted to Mexican children with cancer rep-
resent a major effort toward providing appropriate care for these
traditionally underserved patients and represent amodel for other
LMIC across the world (9, 24, 30).
Program Success Based on the Health Systems
Strengthening Principles
In addition to recognizing cultural differences in the St. Jude IOP-
RCHSD-HGT partnership, we employed several guiding Health
Systems Strengthening principles as outlined by Swanson et al.
(18) during the implementation of the program. These principles
include:
1. Holism: One takes a holistic approach when one considers
all systems components, processes, and relationships simul-
taneously. A successful transcultural partnership ultimately
succeeds based on a true bilateral relationship, one where both
institutions work through and improve the processes of the
new oncology unit. Leaders at RCHSD took a holistic approach
with the HGT bymaking at least weekly site visits from 2008 to
2010 and monthly visits afterward and by serving as accessible
day-to-day mentors as problems arose.
2. Context and collaboration: One considers the context when
one considers global, national, regional, and local culture and
politics. Collaboration takes place when long-term, equal,
and respectful relationships are fostered between mentors and
mentees, in all sectors and organizations involved. Since the
inception of the program, one of the priorities has been to fos-
ter an equal, long-term relationship with the leadership at the
HGT, the state government, and the healthcare team in Tijuana.
This spirit of cultural and political sensitivity in relationships
with Mexico’s Secretary of Health, the HGT leadership, local
staff, and patients has been crucial to the success of various
aspects of the program.
3. Social mobilization: Social mobilization refers to efforts that
advocate for social and political change to improve health sys-
tems and social determinants of health. In Tijuana, Patronato
has played a major role, as the main advocate of the children,
impacting the local community and society and leading to
a successful development of the new HGT pediatric cancer
program.
4. Capacity enhancement: This occurs when individuals, com-
munities, ministries of health, and other stakeholders in the
health system become better able to provide for the various
levels of healthcare and accept ownership for doing so. This
is one of the greatest strengths of this particular partnership,
as capacity enhancement has taken place at all levels, such that
there now exists an independently operating pediatric cancer
unit in Baja California for the first time. The Secretary of
Health has become more engaged in supporting the develop-
ment of pediatric cancer services in Mexico, and community
pediatricians and primary care providers in Baja California are
better able to diagnose cancer and refer patients promptly to
the HGT.
5. Equity: One strengthens health systems in an equitable way
when one focuses on and empowers those who are marginal-
ized. The very purpose of this transcultural collaboration is to
reduce health disparities for children with cancer in the border
region and to improve access to care and, ultimately, clini-
cal outcomes. This mission continues to expand as the HGT
has become a regional referral center and agent of healthcare
change. The HGT recently has begun mentoring the Hospital
General de La Paz, Baja California Sur, Mexico, as they seek
to establish the first pediatric cancer unit in the state of Baja
California Sur.
6. Financial protection: Predictable funding streams dramatically
affect the way an organization is able to operate and plan.
The initial shared and realistic budget between St. Jude IOP,
RCHSD, and the HGT was vital to the long-term planning,
local sustainability, and success of the partnership. Specific
training in budgeting and management RCHSD physician
leaders had received prior to the partnership was invaluable.
Predictable funding through Seguro Popular has been crucial
to the success and sustainability achieved thus far.
7. Evidence-informed action: This is when systems and processes
are put in place to gather, analyze and apply local data, make
decisions based on evidence, monitor programs, and strive for
transparency. The HGT has implemented a new data manage-
ment system that allows for analyses of data and helps with
decision-making activities. Also, the transcultural partnership
process was guided according to previously established best
practices from earlier collaborative programs and the team at
the HGT now has access to treatment protocols and therapy
guidelines already developed at RCHSD and St. Jude IOP.
Challenges
The establishment of this partnership has faced some challenges,
including cultural differences between the RCHSD and the HGT
Frontiers in Public Health | www.frontiersin.org June 2015 | Volume 3 | Article 1596
Aristizabal et al. United States-Mexico cross-border cancer disparities
teams. Appointing a bilingual and bicultural physician from
RCHSD (PA) to serve as the project medical director was the first
step in overcoming those barriers. More effective communication
in the language spoken at the partner site facilitatedmutual under-
standing. The net result of this dynamic was that theHGThospital
administrators, physicians, nurses, and staff were empowered to
take ownership of the evolving cancer program.
A crucial element of the new unit that required creativity and
commitment was the constant adaptation of the delivery of care
by the HGT staff to the constantly changing amount of resources
available to them; during these uncertain times, it was important
to find ways to move forward and make improvement, and not
wait for situations outside the hospital to change (10).
Despite their commitment to the cause, individual healthcare
workers still face their own limits while caring for children with
complex, life-threatening treatment complications. These profes-
sionals often have a high work load, may receive lower salaries,
and often feel undervalued. Employee motivation and morale can
suffer as a result. One of the solutions has been the implementa-
tion of innovative incentive programs for nurses and allied staff to
reward their efforts to provide excellent care.
A limitation of the interpretation of our results is that we
were not able to compare the survival rates at the HGT with
other similar pediatric oncology units in Mexico in an individ-
ualized manner or to those obtained in well-established pediatric
oncology centers such as Instituto Nacional de Pediatria, Hospi-
tal Infantil de Mexico, or Instituto Mexicano de Seguro Social,
given the scarcity of published data in the field (24). In addition,
there is no national cancer registry in Mexico; however, there are
emerging efforts that started in 2007 to obtain epidemiological
data at least for the cases identified through the Seguro Popular
system (11, 12). Moreover, we could not assess differences on
clinical outcomes in private institutions such as Hospital ABC or
Hospital Angeles given that only 5–7% of children in Mexico are
privately insured, thus data on these patients would be insufficient
for meaningful comparisons.
Knowledge Sharing
Engaging in this transcultural partnership has not only benefited
cancer patients in Baja California. As stakeholders of the St. Jude
IOP-RCHSD-HGT partnership learned a unique body of knowl-
edge, such as techniques to reduce treatment abandonment rates
in Tijuana, physicians in San Diego applied those principles to
help with their patients with high risk for abandonment of ther-
apy among their own underserved Hispanic population. Aban-
donment is not a problem frequently encountered by pediatric
oncologists in theUS, thus providers often lack the training to deal
with families, especially large, involved Hispanic families, when
this difficult situation arises. The team in San Diego has learned
from the team in Tijuana to adequately address issues with these
families in a culturally sensitive and tailored way; they are now
cognizant of and respectful of their specific beliefs and Hispanic
family values.
In addition, whenmade aware of the realities faced in resource-
restrained settings through the close working relationships with
the pediatric cancer service in Tijuana, the team and leaders in San
Diego have grown to better appreciate the precious and sometimes
perceived as “unlimited” resources in the US. This realization
has resulted in more cost-conscious medical care by the team at
RCHSD.
Going Forward
Despite all these improvements, 50% of the total expected number
of new cases of pediatric cancer in Baja California are still not
diagnosed or treated in the current pediatric cancer unit at the
HGT. The distribution of the pediatric cancers currently treated
at the HGTmimics the epidemiology of pediatric cancers in other
areas of the world (11, 12, 19). According to recent Mexican
Census data, one would expect about 200 new pediatric cancer
cases per year in Baja California (7, 31). There may actually be
even more annual cases because about 130,000 new immigrants
move to the state each year and thus Census population data may
not reflect these additional inhabitants.
Based on data obtained from the HGT’s newly established
institutional registry between 2008 and 2014, the number of new
cases per year has risen from about 20 to about 70, which is the
number of expected cases solely for the population of Tijuana.
About 35% of patients treated at the HGT come from outside the
city, so while access to care has increased for children with cancer
in Tijuana and Baja California, there are still children both in the
city of Tijuana and in the state who are not receiving the life-saving
care they need.
Looking to the future, efforts will concentrate around
improving further the care, the infrastructure, and promoting
awareness of pediatric cancer in Baja California. The community
outreach programs will continue to train pediatricians, primary
care providers, and health “promotores” throughout the state
in order to prepare them to detect pediatric cancer earlier in
communities state wide.
Initiatives going forward include:
1. Completing the HGT pediatric cancer unit’s transformation
into a regional referral center that provides high-quality pedi-
atric oncology care in Mexico and becoming a mentor for
the Hospital General in La Paz, Baja California Sur and other
hospitals in the region.
2. Furthering innovations to retain the nursing staff and other
healthcare workers and keep them motivated.
3. Continuing to grow the “physician–extender” training and
retention program, with the hope that palliative care and neu-
rosurgery services can be added to those available to patients
and their families at the HGT in the future.
Conclusion
One of the critical factors for the long-term success of any col-
laborative transcultural program is to pursue healthy, long-term,
and culturally sensitive relationships with government leaders and
other stakeholders in the LMIC. Budgeting training and manage-
rial skills are essential, as well as predictable and sustainable fund-
ing sources. Adherence to other Health Systems Strengthening
principles enhances the likelihood of program success.
One of the short-term goals of all transcultural partnerships
in pediatric oncology should be to improve clinical outcomes
for children in LMICs. The long-term goal of all collabora-
tive partnerships should be to transform an emerging pediatric
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oncology unit into an independent, high-quality, referral center
that can initiate other local and regional collaborations.
There is a vast need for overcoming health disparities along
the border region for both adults and children with various
health conditions such as cardiac, infectious, metabolic, and sur-
gical, among others; this represents a remarkable opportunity
for improvement among clinicians, government officials, public
health professionals, and other stakeholders on both sides of the
border. The process that transcultural partnerships have devel-
oped to overcome health disparities is proven and could be applied
to other disciplines of medicine.
Even within the HGT, where pediatric cancer care has already
experienced dramatic improvements and where other physicians
and departments havewitnessed the success of this program, there
are several opportunities to establish similar collaborations. Next
steps could include engagement of key stakeholders on both sides
of the border with a willingness to overcome any cultural and
system barriers.
We invite pediatric cancer centers and academic institutions in
LMIC and HIC to consider taking action regarding this ethical
dilemma by initiating culturally sensitive, long-term collabora-
tions with a sister organization in any discipline of medicine.
We also encourage the enactment of policies that promote and
facilitate such equitable, long-term transcultural partnerships.
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